NVST
Price
$25.30Alerts
Change
-$0.54 (-2.09%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
4.04B
91 days until earnings call
Intraday BUY SELL Signals
PLSE
Price
$56.98Alerts
Change
+$1.86 (+3.37%)
Updated
Nov 11 closing price
Capitalization
3.8B
141 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NVST vs PLSE

NVST vs PLSE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NVST vs. PLSE commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and PLSE is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for NVST with price predictions
Nov 10, 2026

NVST in upward trend: 10-day moving average crossed above 50-day moving average on November 05, 2026

The 10-day moving average for NVST crossed bullishly above the 50-day moving average on November 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on NVST as a result. In 71 of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.

The Moving Average Convergence Divergence (MACD) for NVST just turned positive on October 06, 2026. Looking at past instances where NVST's MACD turned positive, the stock continued to rise in 35 of 49 cases over the following month. The odds of a continued upward trend are 71%.

NVST moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVST advanced for three days, in 171 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 105 of 155 cases where NVST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.

Bearish Trend Analysis

The 10-day RSI Indicator for NVST moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 18 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 63 cases where NVST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.

The 50-day moving average for NVST moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

NVST broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. NVST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.314) is normal, around the industry mean (4.964). P/E Ratio (42.661) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.451) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for PLSE with price predictions
Nov 10, 2026

PLSE in upward trend: 10-day moving average moved above 50-day moving average on October 29, 2026

The 10-day moving average for PLSE crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 18 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on PLSE as a result. In 79 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.

The Moving Average Convergence Divergence (MACD) for PLSE just turned positive on October 22, 2026. Looking at past instances where PLSE's MACD turned positive, the stock continued to rise in 48 of 55 cases over the following month. The odds of a continued upward trend are 87%.

PLSE moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +9.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where PLSE advanced for three days, in 223 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 51 cases where PLSE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLSE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.

PLSE broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PLSE entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. PLSE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PLSE's P/B Ratio (38.199) is very high in comparison to the industry average of (4.964). P/E Ratio (-45.547) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. PLSE's P/S Ratio (2500.000) is very high in comparison to the industry average of (56.876).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
NVST vs PLSE: Fundamental Ratings
NVST
PLSE
OUTLOOK RATING
1..100
4227
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
10030
SMR RATING
1..100
8798
PRICE GROWTH RATING
1..100
4434
P/E GROWTH RATING
1..100
9697
SEASONALITY SCORE
1..100
501

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (64) in the null industry is in the same range as PLSE (80) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Profit vs Risk Rating (30) in the Medical Specialties industry is significantly better than the same rating for NVST (100) in the null industry. This means that PLSE’s stock grew significantly faster than NVST’s over the last 12 months.

NVST's SMR Rating (87) in the null industry is in the same range as PLSE (98) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PLSE’s over the last 12 months.

PLSE's Price Growth Rating (34) in the Medical Specialties industry is in the same range as NVST (44) in the null industry. This means that PLSE’s stock grew similarly to NVST’s over the last 12 months.

NVST's P/E Growth Rating (96) in the null industry is in the same range as PLSE (97) in the Medical Specialties industry. This means that NVST’s stock grew similarly to PLSE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTPLSE
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 7 days ago
71%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 24 days ago
70%
Bearish Trend 27 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
85%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (NVST: $25.84 vs. PLSE: $55.12)
Brand notoriety: NVST and PLSE are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NVST: 68% vs. PLSE: 93%
Market capitalization -- NVST: $4.04B vs. PLSE: $3.8B
NVST [@Pharmaceuticals: Other] is valued at $4.04B. PLSE’s [@Pharmaceuticals: Other] market capitalization is $3.8B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green while PLSE’s FA Score has 1 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • PLSE’s FA Score: 1 green, 4 red.
According to our system of comparison, PLSE is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 6 TA indicator(s) are bullish while PLSE’s TA Score has 5 bullish TA indicator(s).

  • NVST’s TA Score: 6 bullish, 5 bearish.
  • PLSE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both NVST and PLSE are a good buy in the short-term.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а +4.32% price change this week, while PLSE (@Pharmaceuticals: Other) price change was +5.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.

Reported Earning Dates

NVST is expected to report earnings on Feb 10, 2027.

PLSE is expected to report earnings on Apr 01, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+1.96% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TPHD44.250.08
+0.18%
Timothy Plan High Dividend Stock ETF (TPHD)
SPMV50.75N/A
N/A
Invesco S&P 500 Minimum Variance ETF
PCPP27.62N/A
N/A
Porter & Company Porter Portfolio Index ETF (PCPP)
RZG61.96-0.08
-0.13%
Invesco S&P Smallcap 600 Pure Growth ETF (RZG)
BFLX24.96-0.08
-0.32%
iShares Flexible Equity Active ETF (BFLX)